13.3 Analgesics, Anxiolysis & Sedation
Key Takeaways
- NSAIDs are first-line for inflammatory dental pain when not contraindicated (GI ulcer, significant renal disease, late pregnancy, NSAID-exacerbated respiratory disease); acetaminophen is the primary alternative and combination partner.
- Opioids are second-line short-course options for severe acute pain; avoid routine combinations with benzodiazepines/alcohol and respect codeine CYP2D6 pediatric safety limits.
- Nitrous oxide–oxygen offers titratable anxiolysis with rapid recovery; end with 100% oxygen to prevent diffusion hypoxia and respect pregnancy/respiratory contraindications.
- Oral conscious sedation requires training, monitoring, escort home, and flumazenil readiness while remaining in minimal-to-moderate sedation on the continuum toward general anesthesia.
- ASA physical status (I–VI) guides venue and sedation depth: ASA I–II fit most office care; ASA III needs caution/consult; ASA IV+ is generally inappropriate for routine outpatient oral sedation.
13.3 Analgesics, Anxiolysis & Sedation
Quick Answer: Dental pain is usually inflammatory—NSAIDs (ibuprofen, naproxen) are first-line when not contraindicated; acetaminophen is the main alternative/add-on; opioids are reserved for severe acute pain short-term with caution. Nitrous oxide–oxygen provides titration-friendly anxiolysis with rapid recovery. Oral conscious sedation (e.g., benzodiazepines) requires training, monitoring, and strict patient selection. Always stratify risk with ASA physical status, medical history, airway, and fasting/escort rules appropriate to sedation depth.
This section closes the LA/analgesia chapter by moving from chairside nerve blocks to post-operative pain control and anxiety/sedation pathways—high-yield for both pharmacology (~14% AFK domain family) and safe clinical judgment.
Pain Physiology Relevant to Drug Choice
Nociception from pulpitis, extraction sockets, and surgical trauma is driven by prostaglandins, bradykinin, histamine, and central sensitization. Blocking prostaglandin synthesis with NSAIDs attacks the source of much dental pain more effectively than opioids alone for many post-extraction and endodontic scenarios. Combining peripheral (NSAID) and central (acetaminophen ± limited opioid) mechanisms is the modern multimodal approach.
| Analgesic class | Primary mechanism (teaching) | Best dental role |
|---|---|---|
| NSAIDs | COX inhibition → ↓ prostaglandins | First-line inflammatory dental pain |
| Acetaminophen | Central COX/peroxidase pathways (not fully settled); antipyretic | When NSAIDs contraindicated; combination therapy |
| Opioids | μ-receptor agonists in CNS | Severe acute pain, short courses, second-line |
| Corticosteroids | Broad anti-inflammatory gene effects | Selected surgical swelling protocols (not routine OTC pain) |
| Long-acting LA | Peripheral Na⁺ channel block | Pre-emptive/prolonged post-op numbness (bupivacaine) |
NSAIDs
Common agents: ibuprofen, naproxen, diclofenac, ketorolac (potent; short-term), celecoxib (COX-2 selective).
| Topic | AFK points |
|---|---|
| Efficacy | Ibuprofen 400–600 mg often equals or beats combination opioid-acetaminophen for many dental pains in studies—know the principle |
| Ceiling | Analgesic ceiling exists; escalating beyond anti-inflammatory doses adds adverse effects more than analgesia |
| GI risk | Dyspepsia, ulcer, bleeding—worse with age, prior ulcer, anticoagulants, corticosteroids, alcohol |
| Renal | Afferent arteriolar prostaglandins protect GFR in low-flow states—caution in dehydration, CKD, ACEI/ARB + diuretic (“triple whammy”) |
| CV | Some NSAIDs raise CV event risk with chronic use; balance against benefit for short dental courses |
| Platelets | Non-selective NSAIDs inhibit platelet function (aspirin irreversible; others reversible)—surgical bleeding consideration |
| Asthma/allergy | Aspirin-exacerbated respiratory disease: avoid non-selective NSAIDs |
| Pregnancy | Avoid especially 3rd trimester (ductus arteriosus, oligohydramnios concerns)—use current obstetric guidance; acetaminophen often preferred |
| Interaction | ↑ bleeding with warfarin/DOACs/SSRIs; attenuate antihypertensives; methotrexate toxicity risk |
Ketorolac is useful short-term for moderate–severe pain but limited duration (days) because of GI/renal toxicity—not a casual multi-week dental script.
Acetaminophen (Paracetamol)
| Feature | Detail |
|---|---|
| Role | Analgesic/antipyretic without significant anti-inflammatory effect at usual doses |
| When first choice | NSAID contraindication (ulcer, CKD, late pregnancy, NSAID allergy, anticoagulation concerns) |
| Combination | With ibuprofen (staggered or combined protocols) improves analgesia without opioid |
| Toxicity | Hepatotoxicity in overdose; chronic heavy alcohol use, malnutrition, induced CYP enzymes increase risk |
| Max daily dose | Teaching often 3–4 g/day adult maximum depending on jurisdiction/label—count combination products (many opioid combos already contain acetaminophen) |
| Pediatric | Weight-based dosing critical; liquid concentration errors are a classic toxicity path |
AFK trap: patient already taking “extra-strength” acetaminophen OTC + prescribed opioid-acetaminophen → silent hepatic overdose.
Opioids in Dentistry
Agents historically used: codeine, oxycodone, hydrocodone (availability varies by country), tramadol (weak μ agonist + monoamine effects).
| Principle | Application |
|---|---|
| Stewardship | Prefer NSAID ± acetaminophen first; opioids only when expected pain severe or multimodal insufficient |
| Duration | Shortest course (often ≤3 days) for acute post-op pain |
| Adverse effects | Nausea, constipation, sedation, respiratory depression, dependence, diversion |
| Codeine | Prodrug needing CYP2D6 to morphine—ultra-rapid metabolizers (especially children) risk overdose; poor metabolizers get little analgesia; many pediatric restrictions worldwide |
| Tramadol | Seizure risk, serotonin syndrome with SSRIs/SNRIs/MAOIs; still misuse potential |
| Interactions | Additive CNS/respiratory depression with benzodiazepines, alcohol, other sedatives—black-box level concern for opioid + benzo combinations |
| Special populations | Elderly: start low; avoid in active substance use disorder without specialist plan; pregnancy/breastfeeding—prefer non-opioids when possible |
Canadian practice context (concept): emphasize non-opioid first-line dental analgesia consistent with national stewardship messaging; know your provincial prescribing rules beyond AFK science.
Multimodal Post-Operative Pain Ladder (Dental)
- Pre-emptive: long-acting LA at surgery end; consider pre-op NSAID if not contraindicated
- Mild–moderate: ibuprofen (or naproxen) scheduled initially, not only PRN
- Add acetaminophen on schedule staggered with NSAID
- Severe breakthrough: short-course opioid combination or opioid alone if acetaminophen already maxed
- Non-drug: cold packs early, head elevation, soft diet, oral hygiene, patient education (peak pain often 24–48–72 h post-extraction)
Nitrous Oxide–Oxygen Inhalation
N₂O is an inhalational anxiolytic/analgesic adjunct widely used in dentistry.
| Feature | Detail |
|---|---|
| Properties | Low blood:gas solubility → rapid onset and recovery; titration possible |
| Delivery | Fail-safe machines limit minimum O₂ (commonly ≥30% O₂); scavenging mandatory for staff safety |
| Effects | Euphoria, reduced anxiety, mild analgesia, relative analgesia stage; patient remains conscious and responsive at proper titration |
| Technique | 100% O₂ start/end; titrate N₂O in 10% steps typically; watch for oversedation (mouth breathing, agitation, nausea) |
| Diffusion hypoxia | At end, N₂O leaves blood into alveoli and can dilute O₂—give 100% O₂ for several minutes before dismissing |
| Contraindications / cautions | Nasal obstruction, COPD/severe respiratory compromise, middle ear/sinus surgery recent, bleomycin history (O₂ issues), first trimester pregnancy (avoid elective), vitamin B₁₂ deficiency/chronic exposure neuropathy (staff), inability to understand/cooperate, severe claustrophobia with mask, some psychiatric instability |
| Advantages | Non-invasive, titratable, rapid recovery, no escort often required at pure N₂O levels (jurisdiction/office policy) |
| Limitations | Not adequate alone for highly invasive procedures in extremely phobic patients; nausea possible; requires nasal breathing |
Oral Conscious Sedation Principles
Oral sedation (commonly benzodiazepines such as triazolam, diazepam, lorazepam—agent availability varies) produces minimal to moderate sedation when used appropriately—not general anesthesia.
| Domain | Requirements / teaching points |
|---|---|
| Goals | Anxiolysis, cooperation, amnesia possible; maintain independent airway and response to verbal command (moderate sedation definition teaching) |
| Training & permit | Jurisdictional permits, ACLS/emergency readiness, team roles—AFK tests principles not provincial form numbers |
| Patient selection | ASA I–II ideal; ASA III only with caution/consult; avoid complex airway, severe OSA without specialist setting, severe GERD/aspiration risk poorly controlled |
| Pre-op | Full medical/drug history, NPO guidelines per depth, escort home mandatory for oral sedatives that impair cognition, written consent, baseline vitals |
| Dosing | Lowest effective dose; account for age, liver disease, concurrent opioids/alcohol; no redosing casually from waiting-room “top-ups” without protocol |
| Monitoring | BP, pulse, SpO₂, clinical responsiveness; continuous observation; supplemental O₂ as indicated |
| Reversal | Flumazenil reverses benzodiazepines (seizure risk in chronic benzo users; resedation possible—monitor length) |
| Discharge | Stable vitals, oriented, ambulating with escort, written post-op instructions, emergency contacts |
| Dangerous combinations | Oral benzo + opioid + antihistamine “stacks” → respiratory depression; polypharmacy is a major morbidity pathway |
Minimal vs moderate vs deep sedation vs GA (continuum):
| Level | Responsiveness | Airway |
|---|---|---|
| Minimal (anxiolysis) | Normal response to verbal | Unaffected |
| Moderate (conscious) | Purposeful response to verbal/tactile | No intervention needed |
| Deep | Response after repeated/painful stimulation | May need airway help |
| General anesthesia | Unarousable | Often impaired; advanced airway support |
Dentists must not drift into unintended deep sedation without training, monitors, and rescue capability.
ASA Physical Status Classification
The American Society of Anesthesiologists (ASA) physical status score stratifies systemic disease burden for anesthesia/sedation risk communication.
| ASA | Definition (teaching) | Dental examples |
|---|---|---|
| I | Normal healthy patient | Healthy adult, non-smoker |
| II | Mild systemic disease | Controlled HTN, controlled diabetes, mild asthma, pregnancy, obesity mild, smoker |
| III | Severe systemic disease, not incapacitating daily function fully | Uncontrolled DM/HTN, stable CAD, COPD, morbid obesity, hepatitis with functional impact |
| IV | Severe systemic disease that is a constant threat to life | Unstable angina, advanced COPD on O₂, symptomatic heart failure, hepatorenal failure |
| V | Moribund, not expected to survive without operation | Not typical outpatient dentistry |
| VI | Brain-dead organ donor | N/A to routine dental |
AFK use of ASA:
- Match venue and sedation depth to ASA (ASA IV generally hospital/specialist anesthesia—not routine oral sedation in general practice).
- Combine ASA with procedure stress, airway exam (Mallampati concept recognition), and functional capacity.
- Reassess after MI, stroke, recent stents—timing rules for elective care live in medical-emergency/medically compromised chapters but ASA flags urgency of consult.
Putting It Together: Clinical Vignette Patterns
- Healthy anxious ASA I, simple extraction: LA + behavioral management ± N₂O; ibuprofen ± acetaminophen post-op.
- ASA II controlled HTN, molar endo: limit epinephrine cartridges, profound LA, NSAID if renal OK and not interacting with antihypertensives excessively.
- Peptic ulcer history: acetaminophen ± carefully considered COX-2 or gastroprotection strategies—not unrestricted ibuprofen.
- Child post-op pain: weight-based acetaminophen/ibuprofen; avoid codeine; warn about soft-tissue biting after LA.
- Phobic ASA II for multiple extractions: trained provider, oral moderate sedation or N₂O, escort, monitoring; not deep sedation in under-equipped office.
- ASA III unstable cardiac: defer elective care; medical consult; hospital/sedation specialist if urgent dental infection.
Rapid review list
- NSAIDs first for inflammatory dental pain; watch GI, renal, platelet, pregnancy
- Acetaminophen: safe alternative; liver ceiling; combination-product trap
- Opioids short, second-line; avoid routine benzo + opioid stacks
- N₂O: titrate, scavenger, 100% O₂ at end (diffusion hypoxia)
- Oral sedation: selection, monitoring, flumazenil, escort, permit/training
- ASA I–II outpatient friendly; III caution; IV+ not routine office oral sedation
- Multimodal > opioid-only for most dental surgery pain
Master drug tables from 13.1, techniques from 13.2, and this section’s analgesic/sedation ladder—you now cover the AFK local anesthesia and analgesia cluster end-to-end before systemic pharmacology and medical emergencies expand the same safety themes.
For most healthy adults after routine dental extractions, which analgesic strategy is most appropriate as first-line therapy?
Which instruction is most important at the conclusion of nitrous oxide–oxygen sedation?
An ASA III patient is best described as which of the following?
Which statement about oral benzodiazepine conscious sedation is correct?